Justin Xavier Moore, PHD

Assistant Professor

PhD (Epidemiology), University of Alabama at Birmingham, Birmingham, AL, 2017
MPH (Epidemiology), University of Alabama at Birmingham, Birmingham, AL, 2014

(706) 721-5757
room number AE-1037


Dr. Moore is an epidemiologist with vast skills in biostatistics, epidemiology, database design, geographic information systems (GIS), mediation analysis and cancer prevention and control. Dr. Moore joined Augusta University in 2019 as an Assistant Professor in the Division of Epidemiology, Department of Population Health Sciences (DPHS). Dr. Moore received his PhD in Epidemiology from University of Alabama at Birmingham (UAB) School of Public Health followed by his post-doctoral training under the National Institutes of Health funded T32 Cancer Prevention and Control Training Program at Washington University in Saint Louis School of Medicine. Dr. Moore’s research explores the intersection between race (including effects of racism) and place (social and built environment) on various health outcomes including cancer and infectious diseases. Dr. Moore’s work delineated that place matters for African American, Hispanic, and rural populations characterized by hot spots of excess mortality from breast cancer, lung cancer, early-onset colorectal cancer, sepsis, and COVID-19. Dr. Moore’s current research interests lie in understanding the effects of race and place on determinants of breast cancer including; breast cancer screening, mammographic density, life-course stress, and DNA methylation.

 Dr. Moore currently serves as principal investigator of the Geographic and Racial Disparities in Mammography Screening and Barriers to Receiving Care study funded by the National Institutes of Health, National Institute on Minority Health and Health Disparities (K01MD015304-01). Link to NIH report here: Justin Moore K01

News and Media:

See exclusive interview between Dr. Moore and local news Anchor Brad Means entitled “Where you live could impact your colon cancer risk” on Channel 6 WJBF’s The Means Report: https://www.wjbf.com/featured/the-means-report/where-you-live-could-impact-your-colon-cancer-risk/ 

Dr. Moore’s work on geographic “hot spots” of breast cancer mortality within the United States was highlighted by national public radio:

 St. Louis NPR Report

 Dr. Moore’s work on COVID-19 disparities in Georgia have been highlighted by local WRDW news:

 WRDW News Report




STAT 7070 – Biomedical Statistics



Link to All publications here:
  • Moore JX, Langston ME, George V, Coughlin SS. Epidemiology of the 2020 Pandemic of COVID-19 in the State of Georgia: Inadequate Critical Care Resources and Impact after seven weeks of Community Spread. JACEP Open 2020, in press.
  • Moore JX, Han Y, Appleton C, Colditz G, Toriola AT. Determinants of Mammographic Breast Density by Race Among a Large Screening Population. JNCI Cancer Spectr. 2020 Apr;4(2):pkaa010. doi: 10.1093/jncics/pkaa010. eCollection 2020 Apr. PubMed PMID: 32373777; PubMed Central PMCID: PMC7192029.
  • Moore JX, Carter SJ, Williams V, Khan S, Lewis-Thames MW, Gilbert K, Howard G. Physical health composite and risk of cancer mortality in the REasons for Geographic and Racial Differences in Stroke Study. Prev Med. 2020 Mar;132:105989. doi: 10.1016/j.ypmed.2020.105989. Epub 2020 Jan 16. PubMed PMID: 31954141; PubMed Central PMCID: PMC7048236
  • Moore JX, Royston KJ, Langston ME, Griffin R, Hidalgo B, Wang HE, Colditz G, Akinyemiju T. Mapping hot spots of breast cancer mortality in the United States: place matters for Blacks and Hispanics. Cancer Causes Control. 2018 Aug;29(8):737-750. doi: 10.1007/s10552-018-1051-y. Epub 2018 Jun 19. PubMed PMID: 29922896; PubMed Central PMCID: PMC6301114. 
  • Moore JX, Akinyemiju T, Bartolucci A, Wang HE, Waterbor J, Griffin R. A prospective study of cancer survivors and risk of sepsis within the REGARDS cohort. Cancer Epidemiol. 2018 Aug;55:30-38. doi: 10.1016/j.canep.2018.05.001. Epub 2018 May 25. PubMed PMID: 29763753; PubMed Central PMCID: PMC6054880. 
  • Moore JX, Akinyemiju T, Bartolucci A, Wang HE, Waterbor J, Griffin R. Mediating Effects of Frailty Indicators on the Risk of Sepsis After Cancer. J Intensive Care Med. 2018 Jan 1;:885066618779941. doi: 10.1177/0885066618779941. [Epub ahead of print] PubMed PMID: 29862879; PubMed Central PMCID: PMC6026551. 
  • Xavier Moore J, Donnelly JP, Griffin R, Safford MM, Howard G, Baddley J, Wang HE. Community characteristics and regional variations in sepsis. Int J Epidemiol. 2017 Oct 1;46(5):1607-1617. doi: 10.1093/ije/dyx099. PubMed PMID: 29121335; PubMed Central PMCID: PMC6455035. 
  • Moore JX, Akinyemiju T, Wang HE. Pollution and regional variations of lung cancer mortality in the United States. Cancer Epidemiol. 2017 Aug;49:118-127. doi: 10.1016/j.canep.2017.05.013. Epub 2017 Jun 9. PubMed PMID: 28601785; PubMed Central PMCID: PMC5553699. 9.
  • Moore JX, Chaudhary N, Akinyemiju T. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev Chronic Dis. 2017 Mar 16;14:E24. doi: 10.5888/pcd14.160287. PubMed PMID: 28301314; PubMed Central PMCID: PMC5364735.
  • Moore JX, Zakai NA, Mahalingam M, Griffin RL, Irvin MR, Safford MM, Baddley JW, Wang HE. Hemostasis biomarkers and risk of sepsis: the REGARDS cohort. J Thromb Haemost. 2016 Nov;14(11):2169-2176. doi: 10.1111/jth.13446. Epub 2016 Sep 23. PubMed PMID: 27512924; PubMed Central PMCID: PMC5503746.